Alternative Data for DarioHealth
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 9 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 18,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| App Downloads | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 237 | Sign up | Sign up | Sign up |
| Facebook Followers | 71,213 | Sign up | Sign up | Sign up |
| Instagram Followers | 7,467 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,527 | Sign up | Sign up | Sign up |
| X Followers | 7,995 | Sign up | Sign up | Sign up |
| X Mentions | 2 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 1,810 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 44 | Sign up | Sign up | Sign up |
| Linkedin Employees | 240 | Sign up | Sign up | Sign up |
About DarioHealth
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand.
| Price | $12.22 |
| Target Price | Sign up |
| Volume | 5,370 |
| Market Cap | $83M |
| Year Range | $6.17 - $17.35 |
| Dividend Yield | 0% |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
DarioHealth announces 79 new accounts signed year-to-dateDecember 2 - Thefly.com |
 |
What Catalysts Are Changing the Narrative for DarioHealth?November 30 - Yahoo |
|
DarioHealth announces publication of study in JMIR on digital health platformNovember 24 - Thefly.com |
 |
DarioHealth price target raised by $10.40 at TD Cowen, here's whyNovember 14 - Thefly.com |
|
DarioHealth price target lowered to $16 at Stifel after reverse stock splitNovember 14 - Thefly.com |
 |
DarioHealth reports Q3 EPS ($2.96), consensus ($2.42)November 13 - Thefly.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 5M | 2M | 3M | -2.1M | -8.7M | -2.221 |
| Q2 '25 | 5.4M | 2M | 3.4M | -13M | -8.4M | 0.180 |
| Q1 '25 | 6.8M | 2.9M | 3.9M | -9.2M | -8.2M | -0.119 |
| Q4 '24 | 7.6M | 2.1M | 5.5M | -9.6M | -8.4M | -0.043 |
| Q3 '24 | 7.4M | 2.2M | 5.2M | -12M | -10M | -0.250 |
Insider Transactions View All
| Nelson Steven Charles filed to buy 95,000 shares at $0.5. August 27 '25 |
| Nelson Steven Charles filed to buy 55,000 shares at $0.9. November 14 '24 |
| Nelson Steven Charles filed to buy 50,000 shares at $0.8. September 12 '24 |
| Nelson Steven Charles filed to buy 40,000 shares at $0.8. September 10 '24 |
Similar companies
Read more about DarioHealth (DRIO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - DarioHealth
The Market Cap of DarioHealth is $83M.
Currently, the price of one share of DarioHealth stock is $12.22.
The DRIO stock price chart above provides a comprehensive visual representation of DarioHealth's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling DarioHealth shares. Our platform offers an up-to-date DRIO stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, DarioHealth (DRIO) does not offer dividends to its shareholders. Investors interested in DarioHealth should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of DarioHealth are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
